An individualized approach to the hypertensive patient with renal disease: six illustrative case studies.
One of the biggest challenges in medicine is the area of therapeutics, wherein the physician attempts to match the needs of the individual patient with a specific agent from the pharmacopeia, at the dose that might be best suited to treat the individual's problem. A great deal of the art of medicine is involved in this "matching process," in which the scientific aspects of diagnosis and therapy meet with the physician's knowledge of clinical pharmacology. The abbreviated case histories of six patients who came to the author with specific questions regarding therapy of their hypertension and renal impairment illustrate the fact that one of any number of therapies might have reduced blood pressure in these patients, but in each, there was a specific reason to attempt a single approach first. If physicians could better understand and extrapolate the results of clinical research to the treatment of specific patients, choice of therapy might become more successful.
Elliott
W J
WJ
Department of Preventive Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612-3824.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000175:diagnosis; D001314:Auscultation; D001581:Benzothiadiazines; D003371:Cough / Q000139:chemically induced; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D004232:Diuretics; D004359:Drug Therapy, Combination; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000145:classification / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008914:Minoxidil / Q000009:adverse effects; D011224:Prazosin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D008914:Minoxidil; D005665:Furosemide; C041226:Terazosin; D014700:Verapamil; D011224:Prazosin